What is the generic version of adagrasib?

Adagrasib (Adagrasib) is a targeted drug for the treatment of non-small cell lung cancer with KRAS G12C mutations. Generic drugs refer to drugs that have similar active ingredients, dosage forms, administration routes and therapeutic effects to the original drug Adagrasib. The emergence of such generic drugs aims to provide patients with treatment options that are similar to the original drugs but at a more affordable price. As adagrasib is an innovative targeted drug, its research and development costs are high, so the price of the original drug is often higher, and the price of the US version may be hundreds of thousands of yuan. Generic drugs can reduce production costs while ensuring drug quality and safety, thereby providing more competitive prices. The price of each box of the Lao version may be more than 4,000 yuan.